A major new study of more than 140,000 men has identified 63 new genetic variations in the DNA code that increase the risk of prostate cancer.

Scientists have identified 80 molecular weaknesses in prostate cancer that could be targeted by drugs – in the largest, most comprehensive study ever conducted into the genes that drive the disease.

People with a gene mutation that confers a very high risk of cancer would benefit from a whole-body MRI scan to detect the disease early, a new study reports.